Comparisons of the ratio of type I collagen (a), the ratio of type III collagen (b), and the Young's modulus in the linear region of the stress-strain curve (c) between the differe... by Chao Wan (309251)

Bayesian <i>z</i>-score of 56 Pathways in Eight categories post- <i>B. melitensis</i> Infection Compared to Controls. by Carlos A. Rossetti (141514)

Data_Sheet_1_Use of Phage Cocktail BFC 1.10 in Combination With Ceftazidime-Avibactam in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Femur Osteomyelitis—A Case Repo... by Karlis Racenis (12451692)

“…In both cases, the required concentration of ceftazidime-avibactam decreased two-fold. This study demonstrates the possible use of bacteriophages and antibiotics in difficult-to-treat bone and soft tissue infections, where the additive effects of phages and antibiotics were observed.…”

Only positive charge is systematically capable of explaining ribosomal slowing, including the severest slowing. by Catherine A. Charneski (205078)

“…Additionally, a greater likelihood of transcript secondary structure at or just before the identified window is associated not with the more occluded windows, but with the less dense (faster translated) ones, and the presence of secondary structure in fact decreases as the difference in ribosomal slowing between the windows increases. …”

Thermogenetic activation in male flies. by Joseph D. Jones (13883524)

Table_1_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.XLSX by Yaqi Li (2936265)

“…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”

Image_2_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.JPEG by Yaqi Li (2936265)

“…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”

Table_2_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOCX by Yaqi Li (2936265)

“…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”

Table_3_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOC by Yaqi Li (2936265)

“…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”

Table_4_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOC by Yaqi Li (2936265)

“…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”

Image_1_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.JPEG by Yaqi Li (2936265)

“…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”

Image_3_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.JPEG by Yaqi Li (2936265)

“…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”

Image_4_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.TIF by Yaqi Li (2936265)

“…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”

The UpSetR plot showing the frequency of the use of a particular method and their intersections in studies on the occurrence of <i>Mycoplasma gallisepticum</i> in wild birds from 1... by Anna Sawicka (180114)

“…The dot pattern shows the intersections between methods used and the vertical bars at the top of the plot show the number of the corresponding intersection, ranked by a decreasing number of studies.</p>…”

The duty cycle of the feet changes with walking speed. by John A. Bender (335471)

“…Each diamond represents the mean and s.e.m. of both stride period and duty cycle for a single bout of walking. (C) Same data as panel A, but with stance phase determined by the TiTa points' <i>z</i>-values, as for the gray boxes in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0013617#pone-0013617-g008" target="_blank">Fig. 8</a>. …”

Using centrosome dynamics to study cytosolic loading of molecular motors. by Rafael A. Longoria (428918)

“…<p>(A)A schematic sketch of a convex-up force-velocity (F–v) relation for a molecular motor shows that the velocity of the motor decreases only slightly up to an opposing load of about one half its stall force then decreases precipitously. …”

SEM micrographs of electrospun NFS in different weight ratios: (a) 3/1 PLLA/PCL, (b) 2/1 PLLA/PCL, and (c) 1/1 PLLA/PCL. by Liang Chen (73736)

Bacterial taxa abundance differ in the inside compared to the outside microenvironments of stool. by Monika A. Gorzelak (781453)

“…<p>A single stool was subsampled five times from the inside environment and five times from the outer environment, DNA was extracted and used to compare bacterial taxa via qPCR. …”

Image_1_Effects of acromegaly treatment on left ventricular systolic function assessed by speckle tracking echocardiography in relation to sex differences: results from a prospecti... by Agata Popielarz-Grygalewicz (15424142)

“…Biochemical control on SRL was achieved in 25.8% of patients after 6 months and complete surgical remission was achieved in 41.7% of patients. TSS resulted in decrease in median (IQR) IGF-1 compared to IGF-1 levels on SRL treatment: from 1.5(1.2-2.5) to 1.3(1.0-1.6) xULN (p=0.003). …”

Image_3_Effects of acromegaly treatment on left ventricular systolic function assessed by speckle tracking echocardiography in relation to sex differences: results from a prospecti... by Agata Popielarz-Grygalewicz (15424142)

“…Biochemical control on SRL was achieved in 25.8% of patients after 6 months and complete surgical remission was achieved in 41.7% of patients. TSS resulted in decrease in median (IQR) IGF-1 compared to IGF-1 levels on SRL treatment: from 1.5(1.2-2.5) to 1.3(1.0-1.6) xULN (p=0.003). …”